Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed PERTH, Australia, Nov. 20, 2025 /PRNewswire/ -- Orthocell ...
A nerve-sparing technique (NeuroSAFE) reduced erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer. A year after surgery, patients randomized to ...
Dr. Scardino answers the question: 'When Is Nerve-Sparing Surgery Refused?' March 16, 2009 -- Question: When is nerve-sparing surgery not an option in the treatment of prostate cancer? Answer: ...
The nerve-illuminating agent rizedisben achieved sustained fluorescence during laparoscopic prostatectomy All nine patients receiving a dose of 3 mg/kg showed obturator nerve fluorescence, as well as ...
Dr. Scardino answers the question: 'Nerve-Sparing Prostatectomy and Potency?' Jan. 01, 2009 -- Question: What is the success rate for maintaining potency after a nerve-sparing prostatectomy? Answer: A ...
However, during standard surgery it can be difficult to determine whether retaining these outer layers risks leaving some cancerous cells behind. In many cases, especially where the tumour is most ...
Patients who underwent NeuroSAFE during nerve-sparing surgery showed improvement in erectile function at 12 months and urinary continence at 3 months. HealthDay News — Use of the NeuroSAFE technique, ...
Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...
The most common surgery for prostate cancer is a radical prostatectomy. This surgery involves taking out the entire prostate gland, some lymph nodes and other nearby tissue, like the seminal vesicles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results